![Jennifer Viera](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Ms. Jennifer Viera is a Head-Investor Relations & Communications at Enanta Pharmaceuticals, Inc. Ms. Viera was previously employed as a Senior Director-Corporate Communications by OvasTem, Inc. and an Investor & Media Contact by Tetraphase Pharmaceuticals, Inc.
Jennifer Viera active positions
| Companies | Position | Start |
|---|---|---|
| ENANTA PHARMACEUTICALS, INC. | Investor Relations Contact | 2022-12-31 |
Former positions of Jennifer Viera
| Companies | Position | End |
|---|---|---|
OvaScience, Inc.
 OvaScience, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of new fertility treatment options for women | Corporate Officer/Principal | - |
| TETRAPHASE PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
16
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel antibiotics | Health Technology |
Enanta Pharmaceuticals, Inc.
 Enanta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs for the treatment of viral infections and liver diseases | Health Technology |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of new fertility treatment options for women | Health Technology |
- Stock Market
- Insiders
- Jennifer Viera
